Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | February 21, 2024 09:06am

Gainers

  • Inspire Veterinary (NASDAQ:IVP) stock increased by 47.8% to $0.2 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.6 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares moved upwards by 47.17% to $0.96. The market value of their outstanding shares is at $1.4 million.
  • Talphera (NASDAQ:TLPH) stock rose 18.39% to $1.48. The market value of their outstanding shares is at $25.0 million.
  • Ocugen (NASDAQ:OCGN) stock increased by 15.38% to $1.2. The company's market cap stands at $307.8 million.
  • Emergent BioSolutions (NYSE:EBS) shares rose 14.8% to $1.75. The market value of their outstanding shares is at $90.5 million.
  • NeoGenomics (NASDAQ:NEO) stock increased by 12.26% to $16.5. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • Avinger (NASDAQ:AVGR) shares decreased by 24.6% to $4.11 during Wednesday's pre-market session. The company's market cap stands at $5.2 million.
  • Biofrontera (NASDAQ:BFRI) shares fell 23.69% to $0.88. The market value of their outstanding shares is at $1.4 million.
  • Teladoc Health (NYSE:TDOC) stock declined by 18.26% to $16.75. The company's market cap stands at $2.7 billion. The company's, Q4 earnings came out yesterday.
  • Chemomab Therapeutics (NASDAQ:CMMB) stock declined by 14.02% to $0.58. The market value of their outstanding shares is at $6.4 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock declined by 12.11% to $0.59. The company's market cap stands at $8.7 million.
  • Trxade Health (NASDAQ:MEDS) stock fell 11.12% to $8.08. The company's market cap stands at $9.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVGR BFRI CMMB EBS IVP MEDS MNPR MOTS NEO OCGN TDOC TLPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist